GT Biopharma, Inc. Common Stock (GTBP)

Typically moves ±33.25% on earnings
EARNINGS ANALYTICS
search

GT Biopharma, Inc. Common Stock (GTBP) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +33.25% (Nov 14, 2025) and its biggest decline was +33.25% (Nov 14, 2025).

Earnings reactions

How GTBP moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±33.25%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Nov 14, 2025 ☀ PRE +33.25% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±33.25%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 12 →
12
Funds holding
$95508
Total value held
Buying
9 added · 2 reduced
Northern Trust Corp
$36953 NEW BUY
Pnc Financial Services Group, Inc.
$19600 NEW BUY
Morgan Stanley
$11054 +35.99%
Stonex Group Inc.
$8667 +57.62%
Wells Fargo & Company/Mn
$7828 -0.32%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
8-K 20260903 open_in_new SEC.gov
10-Q 20260814 open_in_new SEC.gov
8-K 20260814 open_in_new SEC.gov
DEF 14A 20260702 open_in_new SEC.gov
PRE 14A 20260618 open_in_new SEC.gov
8-K 20260612 open_in_new SEC.gov
8-K 20260522 open_in_new SEC.gov
10-Q 20260515 open_in_new SEC.gov
EFFECT 20260513 open_in_new SEC.gov
424B3 20260513 open_in_new SEC.gov

Frequently asked about GTBP earnings

How much does GTBP stock move after earnings? expand_more

Over 1 reports, GTBP has moved an average of ±33.25% the session after earnings, closing higher 100.0% of the time.

What was GTBP's biggest post-earnings move? expand_more

GTBP's largest post-earnings gain on record was +33.25% on Nov 14, 2025, and its largest decline was +33.25% on Nov 14, 2025.

Where can I find GT Biopharma, Inc. Common Stock's SEC filings? expand_more

All of GT Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers